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ABSTRACT 
The capacity of the isolated perfused rat lung to metabolize the protein moieties of 
serum lipoproteins was assessed using homologous (rat) and heterologous (hu- 
man) plasma lipoproteins. The protein and lipid moieties of the plasma lipopro- 
teins were labeled in vitro with Na[~25I]. In selected cases the lipoprotein peptides 
were labeled in vivo with ~4C- or all-labeled amino acids. Uptake of lipoprotein 
label during perfusion was monitored by measure of losses in perfusate label and 
by rises  in  pulmonary tissue  labeling as  shown by radioassay and by light and 
electron microscope radioautography. Lipoprotein degradation was assessed by 
fractionation of perfusate and lung tissue radioactive material into trichloroacetic 
acid (TCA)-insoluble, TCA-soluble, and ether-ethanol-soluble fractions. 
When  heparin  was  included  in  the  perfusion  medium,  there  was  selective 
degradation of the protein portion of very low density lipoprotein (VLDL) in the 
perfusate and concomitant uptake of radioactive label by the lungs. Low density 
lipoprotein (LDL) was neither taken up nor catabolized by the isolated rat lung in 
the absence or presence of heparin. By light and electron microscopy, the label 
was localized over the interalveolar septa, predominantly the capillary endothe- 
lium. Disappearance of TCA-insoluble radioactivity from the perfusate was asso- 
ciated with the generation of both TCA-soluble iodide and noniodide radioactiv- 
ity. Greater than 50% of the radioactive label taken up by the lungs was found in 
the delipidated TCA-insoluble fraction. This study provides in vitro evidence for 
pulmonary catabolism of VLDL apolipoproteins and uptake of peptide catabolic 
products of VLDL by the lung. 
The endothelium of capillaries (8, 41, 45) and of 
large arteries (38, 51, 52) of the systemic  circula- 
tion contains a lipoprotein lipase (LPL)  1  that par- 
ticipates in the hydrolysis and conversion of chy- 
lomicrons (CM) and very low density lipoproteins 
(VLDL) to cholesterol-rich remnants (3,  7,  12- 
Abbreviations  used in this  paper:  BSA, bovine serum 
albumin; CM,  chylomicrons; EDTA,  ethylendiamine- 
tetraacetate; FA, fatty acids; KRB, Krebs-Ringer bicar- 
bonate buffer; LDL, low density lipoproteins; LPL, lipo- 
protein lipase; TCA, trichloroacetic  acid;  VLDL, very 
low density lipoproteins. 
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tains a vast capillary and arterial endothelial bed, 
and  a  pulmonary  LPL active against labeled chy- 
lomicrons has been described (22,  23).  However, 
very little data are available on the metabolism by 
the lung of the circulating lipoproteins in this low 
pressure  vascular  system which is much  less sus- 
ceptible  to  arteriosclerosis  (25).  Previous studies 
have strongly  suggested  that  the lung can hydro- 
lyze endogenous and exogenous triglycerides (15, 
24, 25) perhaps by virtue of its LPL, possibly for 
the  continuous  generation  of free  fatty  acids for 
surfactant  phospholipid  production.  But the data 
available  on  lipoprotein-lipid  degradation  by the 
lungs  are  meager,  and  the  possible  role  of  the 
lungs in metabolizing the protein  moieties of the 
circulating  lipoproteins  remains  virtually  unex- 
plored (33). In the present study with an isolated 
perfused  rat  lung  preparation  (2,  19),  we  have 
investigated  this  problem,  and  our  data  provide 
the first documentation  that  the rat  lung in vitro 
can catabolize the proteins of either rat or human 
VLDL. 
EXPERIMENTAL  PROCEDURE 
Experimental Methods 
ISOLATED  PERFUSED  LUNG:  Male  rats  (200- 
250  g)  were  anesthetized  by  an  injection  of sodium 
pentobarbital (50 mg/kg, body weight) intraperitoneally. 
The animals were artificially ventilated through a trache- 
ostomy by use of a rodent respirator. Via an abdominal 
incision  the inferior vena cava was cannulated and the 
animal  was  perfused  with  warm  (370C)  oxygenated 
Krebs-Ringer bicarbonate buffer (KRB) containing 3% 
bovine serum albumin (BSA) and 0.1% glucose (perfu- 
sion  medium).  Then  the  abdominal  aorta  was  cut  to 
allow  exsanguination.  Subsequently,  the  thorax  was 
opened and the lungs were directly perfused with perfu- 
sion medium through a cannula inserted into the main 
pulmonary artery. The lungs were rapidly freed from the 
heart and mediastinum and connected to a lung perfu- 
sion apparatus  (2,  19)  primed with perfusion medium 
with added lipoproteins and  heparin  (0.1-10.0  U/ml). 
After equilibration of the  system  the  lungs  were sus- 
pended from the trachea and pulmonary  artery into a 
water-jacketed lucite incubation chamber (2) maintained 
at  37~  The  peffusate  dripped  by  gravity  from  the 
pulmonary vein to the bottom of the chamber and was 
recirculated to the lungs after being aerated with 95% O~ 
and 5% CO2. The lungs were ventilated with room air at 
a tidal vol of 2.5 ml and an end-expiratory pressure 1-2 
mm Hg. Complete mixing of the peffusate was insured 
by placing a small magnetic stirrer at the bottom of the 
incubation chamber. Perfusion fluid pH, Po~, and Pco~ 
were continuously measured with an in-flow glass cuvette 
with appropriate electrodes. Pulmonary artery and intra- 
tracheal  pressures  were  continuously  monitored  by 
means of pressure transducers connected to an oscillo- 
scopic  recorder (2).  The perfusion pressure  was  main- 
tained between 8 and 15 mm Hg at a perfusion rate of 10 
ml/min. Duplicate samples of the perfusate for radioas- 
say were taken immediately before connecting the lung 
to the perfusion apparatus and after 10 rain of peffusion 
for equilibration (0 time). Subsequent duplicate samples 
were taken 20, 40, and 60 rain after connecting the lung. 
In the  initial  series of experiments,  at  the  end  of the 
perfusion the lungs were fixed for anatomic studies  by 
intravascular perfusion with 4% paraformaldehyde  and 
2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer 
(pH  7.4,  450  mosmol).  In  a  second  series of experi- 
ments, the lung was homogenized for biochemical stud- 
ies (see below). 
Materials 
Male rats (200-250 g) were supplied by Charles River 
Breeding Laboratories, Wilmington, Mass.  Rodent res- 
piratory and peristaltic pumps were obtained from Har- 
vard Apparatus  Co., Millis, Mass.  and Po~, Pco~,  pH 
electrodes from  Radiometer,  London  Co.,  Cleveland, 
Ohio.  Photographic  emulsions  NTB-2  and  Ilford  L-4 
were purchased from Eastman Kodak, Rochester, N. Y. 
and Ilford Ltd., Iiford, Essex, U. K., respectively. Com- 
mercial sources of chemicals were as follows: Miles Lab- 
oratories, Kankakee, Ill., bovine serum albumin, Frac- 
tion V; Polysciences, Inc., Warrington, Pa., paraformal- 
dehyde, glutaraldehyde, uranyl acetate, and other chem- 
icals  for  electron  microscopy;  New  England  Nuclear, 
Boston,  Mass.,  Na[12~I] (17  Ci/mg)  carrier-free,  [1- 
14C]glycine (47  mCi/mmol),  [2-all]glycerol (200  mCi/ 
retool), and Jail]L-amino  acid mixture. All other chemi- 
cals were of analytical grade. 
Lipoproteins 
ISOLATION OF  VLDL"  Serum  was  obtained  by 
plasmapheresis of a human donor or by bleeding rats via 
the abdominal aorta. Plasma lipoproteins were separated 
by uitracentrifugal flotation in the Spinco model L2-65B 
ultracentrifuge according to Havel et al. (21). Plasma (d 
=  1.006)  containing 1 mg/ml ethylenediaminetetraace- 
tate (EDTA) was centrifuged at 4~  for 16 h at 350,000 
g in the 60 Ti rotor. The superuatant fraction was care- 
fully removed from the top of the tubes with a needle 
and syringe.  The VLDL obtained was purified by two 
subsequent flotations through a layer of saline (0.15 M)- 
EDTA (2 mM) in the 65 rotor. The VLDL migrated as a 
single band with pre-~-mobility during agarose gel elec- 
trophoresis (32). 
ISOLATION  OF  LDL:  The  inftanatant  fraction 
after removal of VLDL was  adjusted  to  a  density  of 
1.063 with a solution of KBr-NaCI (1.35 g/ml) for isola- 
tion of human LDL and to a density of 1.050 for isola- 
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justed fractions was then carried out for 18 h at 350,000 
g in the 60 Ti rotor. The top fraction was twice recentri- 
fuged  in  the  65  rotor  through  a  layer  of  KBr-NaC1 
solution (d  =  1.063).  The purified LDL migrated as a 
single band with fl-mobility during gel electropboresis. 
IOOINATION:  Human or rat VLDL and LDL were 
each iodinated with carrier-free Na[~sI] (17 Ci/mg) by a 
modification (7) of the iodine monochloride method of 
McFadane (34). Rat albumin was also radioiodinated by 
the McFarlane method.  The labeled lipoproteins were 
then  dialyzed  against  three-four  changes  of  sallne- 
EDTA  over a  24-h period.  Labeling efficiency of the 
lipoproteins ranged from 10 to 40%. The labeled lipo- 
proteins contained less than 1 g-atom iodine per 2 x  105 
g  protein.  At  least  92%  of the  labeled  material  was 
TCA-precipitable, and no change in electrophoretic mo- 
bility occurred after lipoprotein iodination. The propor- 
tion of label in human lipoprotein lipids separated  by 
extraction with CHCla-CHaOH  (2:1) by the method of 
Folch  et  al.  (17)  ranged  from  2.6  to  11.0%  for 
[t2sI]VLDL and  0.6  to  0.8%  for [~2SI]LDL, while the 
proportion  of label in  lipids of the  corresponding  rat 
plasma  lipoproteins was  consistently higher. The  per- 
centage distribution of extracted labeled lipids of human 
[~I]VLDL separated by thin-layer chromatography as 
previously described (10) was as follows: phosphollpids 
(33-42%), unesterified cholesterol (18-35%), triglycer- 
ides (7-16%), and esterified cholesterol (2-6%). 
Anatomic Studies 
For  light  microscope  autoradiography,  lung  slices, 
fixed as described earlier, were embedded in methacry- 
late (42);  1-/xm thick sections were coated with Kodak 
NTB-2 emulsion diluted in equal parts of distilled water. 
The sections were exposed for 6 wk at 4*(2 in light-tight 
boxes containing drierite, developed in D-19 (Eastman 
Kodak) full strength, cleared in Hypo, washed in water, 
and stained with hematoxylin eosin. 
For electron microscope autoradiography, small cubes 
of  lung  tissue  were  postfixed  in  2%  OsO4  in  0.1  M 
sodium  cacodylate buffer, stained en bloc with uranyl 
acetate (27), dehydrated in ascending grades of acetone, 
and embedded in Epoxy resin. Sections with silver inter- 
ference color were coated with Ilford L-4 emulsion with 
a Kopriwa coating apparatus (30), exposed for 9-12 wk, 
developed  by  gold  latensification  method  (43),  and 
stained with lead citrate or lead hydroxide. 
Biochemical Studies 
Decline  of radioactivity  was  measured  in  duplicate 
aliquots (2  ml) of perfusate containing labeled human 
lipoproteins. The perfusate samples were precipitated in 
cold 10% trichloroacetic acid (TCA) and the precipitates 
were washed once with 5% TCA. The lipids of the TCA 
precipitates  were  removed  by  extraction  with  ether- 
ethanol  (3:1,  voi/vol) by the  method  of de  Jong and 
Marsh (11). The delipidated TCA-insoluble precipitates 
were dried with ether, dissolved in 88% formic acid, and 
counted in a  Nuclear-Chicago gamma counter with an 
efficiency of 73%. The TCA-soluble fractions were simi- 
larly counted. Thus, both TCA-insoluble and TCA-solu- 
ble fractions were lipid-free in all our experiments. Re- 
suits  were  subjected  to  Student's t  test  for  statistical 
significance. Differences between mean values were con- 
sidered  to  be  statistically significant at  the P  <  0.05 
level. 
In  experiments with  rat  [~25I]VLDL duplicate  2-ml 
aliquots of perfusate were precipitated in 5% TCA. The 
aliquots were separated into precipitate and supernatant 
fractions. The precipitate lipid was extracted as before 
with ether-ethanol, resulting in lipid and protein frac- 
tions. The supernatant iodide was removed with H202 
and CHCIa (4), resulting in iodide and aqueous fractions 
(presumably amino acids and small peptides). All frac- 
tions  were  counted  for  125I label  in  a  Beckman  Bio- 
gamma I (Beckman Instruments, Inc., Spinco Div., Palo 
Alto, Calif.) with an efficiency of 81%. After correcting 
for chloroform absorption of iodine counts, there was 
greater than 90%  recovery of the initial counts in the 
iodine, aqueous, protein, and lipid fractions. 
LUNG  HOMOGENATE:  After  perfusion  with 
[~aI]VLDL the rat lungs were washed with cold perfu- 
sion medium until the effluent contained less than 0.5 % 
of  initial radioactivity.  The  lung  parenchyma was  re- 
moved from supporting structures, frozen in liquid N2, 
and mechanically pulverized. 
Weighed aliquots of lung powder were suspended in 
saline, and precipitated in 5% TCA. Radioactivity in the 
TCA-insoluble and TCA-soluble fractions was assessed 
as described in the preceding section. 
Analysis of Radioautograms 
Light microscope autoradiographic studies were car- 
ried  out  on  11  lungs perfused  with  [~2~I]VLDL, five 
perfused  with  [z~SI]LDL, and  three  perfused  with 
[~25I]albumin. Tissue samples were taken from randomly 
selected areas of three different lobes of each lung. In 
each section, grain density over lung structures was ob- 
tained by determining the number of grains per surface 
area  in  five  randomly  selected  high-power  fields  (x 
1,000).  Surface area was  measured with the aid of an 
ocular micrometer containing evenly spaced grid lines, 
excluding the lumens of the blood vessels. Grain density 
over lung structures was corrected for background radia- 
tion which was measured in a similar manner over parts 
of the slides devoid of lung tissue. 
For electron microscope radioautography, low power 
(x  4,000)  micrographs  were  taken  to  include  every 
developed  grain  seen  over lung  tissue,  excluding  the 
lumens of the capillaries and areas containing faults in 
the sections or emulsions, such as folds, holes, etc. 72 
electron micrographs so obtained were  magnified to a 
final  magnification of  10,000,  and  silver grains were 
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geometric  center fell (18, 44).  The following compart- 
ments were identified: endothelium,  interstitium, type I 
and type II pneumocytes, and an area of alveolar space 
1-2  /zm in width adjacent to the epithelium. 
The  surface  area of each  tissue  compartment  was 
measured  by superimposing over the radiographs  a lat- 
tice with uniformly spaced points (I 8). Grain density was 
obtained by the division of the number of grains by the 
number  of points failing within the various tissue com- 
partments.  Areas that did not contain lung tissue were 
used to determine the background density for each grid. 
Grain density over tissue compartments  was then  cor- 
rected for  background  radiation. Differences  between 
mean values in grain density over various compartments 
were subjected to Student's t test for significance. 
RESULTS 
Criteria of Anatomic and Functional 
Integrity of the Isolated 
Perfused Rat Lungs 
The  preservation  of the  normal  permeability 
characteristics of the pulmonary circulation in our 
preparations was judged by continuous recording 
of perfusion- and end-expiratory pressures and by 
examination of ultra-thin sections by electron mi- 
croscopy. With these criteria, preparations show- 
ing persistent elevation of end-expiratory pressure 
or  ultrastructural  evidence  of  widespread  cell 
damage or interstitial edema were discarded. Pre- 
vious work with isolated perfused rat lungs (D. J. 
P.  Basset,  personal  communication)  has  shown 
that elevation of end-expiratory pressure is a very 
sensitive gauge of interstitial edema that presages 
alveolar edema. It is known that normal pulmo- 
nary capillaries in vivo are virtually impermeable 
to macromolecules of the size of albumin or larger 
(39). In preliminary experiments, the integrity of 
the  pulmonary capillary endothelium  of isolated 
perfused  rat  lungs was  tested by  adding,  to  the 
perfusate, probes for large endothelial leaks (col- 
loidal carbon,  Pelikan  Biological Ink,  Guenther 
Wagner  Pelikan  Co.,  New  York),  or 
[t2~I]albumin. For this purpose, isolated rat lungs 
were perfused for 60-180 min with the complete 
medium plus heparin (2 U/ml). At the beginning 
of  the  peffusion,  colloidal  carbon  (0.1  ml)  or 
[~2r'I]albumin  (1.5  mg) was added. In the case of 
albumin,  perfusate  samples  were  taken  and 
treated  as  described earlier for  lipoproteins.  In 
both groups of experiments, the lungs were exam- 
ined either by conventional transmission electron 
microscopy or by  light and  electron  microscope 
radioautography. No  extravascular accumulation 
of either tracer was detected, indicating that, un- 
der our experimental conditions, the permeability 
of the capillary endothelium of the isolated per- 
fused lung was not distinguishable from that of the 
lung in vivo (39). 
Anatomic Observations 
LIGHT  MICROSCOPE  RADIOAUTOGRAPHY" 
19  lungs  perfused  with  labeled  lipoproteins or 
albumin were utilized for light and electron micro- 
scope autoradiographic observations. Developed 
silver grains in  numbers exceeding that of back- 
ground  were  present only over the interalveolar 
septa of lungs perfused with [12~I]VLDL and hepa- 
rin at dose levels of 2 U/ml or higher. Silver grains 
were  distributed focally near  the  capillary walls 
and  over  alveolar septal  cells  located  predomi- 
nantly at the confluence of two or more alveolar 
septa (Fig,  I); however, precise identification of 
cell types incorporating radioactive label could not 
be  made  with  confidence  with  the  light  micro- 
scope.  No  uptake  of radioactive label was  seen 
over extra-alveolar structures (large blood vessels, 
conducting airways, or visceral pleura), In areas of 
uptake, the density of developed silver grains over 
the interalveolar septa after correction for back- 
ground averaged 7.1  *-  1.9 SEM per 100 ~m  2 of 
lung tissue (P <  0.001). 
ELECTRON  MICROSCOPE  RADI OAUTOGRA- 
PHY:  The  sites  of  uptake  of  radioactive  label 
were  more  clearly identified by electron micros- 
copy. Silver grains over lung tissue were  present 
only in micrographs of lungs perfused with VLDL 
and  heparin  at  concentrations which  resulted in 
biochemical evidence of uptake of radioactive la- 
bel. The  label was most frequently located over 
capillary endothelial cytoplasmic processes  (Fig. 
2) or attached to the luminal surface of capillary 
endothelial  cells  (Fig.  3).  Several  grains  were 
found over interstitial cells, the ground substance 
of the interstitial space, the cytoplasmic processes 
of type I pneumocytes, or cytoplasmic organelles 
of type II pneumocytes (Fig. 4). Since the overall 
number of grains was small, no attempt was made 
to  establish  any  preferential  distribution  of the 
label over intracellular structures. Nevertheless, in 
endothelial and epithelial cells, most grains were 
located  over  areas  of the  cytoplasm  containing 
plasmalemmal vesicles (Fig. 2) or profiles of endo- 
plasmic reticulum. Only few  grains were distrib- 
uted over mitochondria or nuclei. Only rarely was 
label found  over the  lamellar bodies of type  II 
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thick methacrylate-embedded  section of a rat lung per- 
fused  with  [~5I]VLDL  and  heparin  (2  U/ml).  Silver 
grains (thick arrows), representing  the isotope, are seen 
over two cells near the confluence of three interalveolar 
septa. Two endothelial cells (fine arrow) contain  silver 
grains, although  not so clearly seen as in the other two 
cells. The lumens of the alveolar capillaries contain only 
rare  grains  representing  background  radiation. ALV, 
alveolar space,  ￿  750. 
pneumocytes  (Fig. 4).  As indicated in the  histo- 
gram  (Fig.  5),  all compartments  of the  alveolar 
septa had significantly higher density of label than 
did the neighboring alveolar spaces, but the high- 
est concentration of label was over the endothe- 
lium.  The  difference  in  mean  grain  density  be- 
tween the endothelium and the other tissue com- 
partments was statistically significant (P <  0.02). 
Since the silver grains are sometimes so large that 
they  may  overlie adjacent  tissue  compartments, 
either compartment could be the source of radio- 
activity responsible for the developed grains. Ac- 
cordingly,  the  concentration  of grains  over  the 
various  compartments  of  the  alveolar  capillary 
membrane  should  be  taken  to  indicate  a  trend 
rather  than  the  absolute  distribution  of  label 
throughout interalveolar septa. 
Loss  of  radioactive  label  during  fixation  and 
dehydration  from  lungs  that  had  been  perfused 
with  ['zsI]VLDL and  heparin was determined in 
duplicate experiments, As shown  in Table I, the 
label  in  the  acetone  extracts  of  the  lungs  was 
negligible even  in  absence  of osmium  tetroxide 
fixation  and  uranyl  acetate  en  bloc  staining. 
Hence, the radioactivity in lung lipids was proba- 
bly quite low. 
Biochemical Observations 
UPTAKE  AND  DEGRADATION  OF  HUMAN 
[1251]VLDL"  Lungs  were  perfused  with 
[~2~I]VLDL in the absence or presence of heparin, 
an activator of LPL of various tissues (8, 31,49). 
It was  presupposed that  this  enzyme  might  play 
some  initiating role  in  the  pulmonary  metabolic 
handling of circulating lipoproteins. For studies of 
human lipoprotein catabolism, heparin concentra- 
tions of 0.1 and 2 U/ml were tested in our system 
which  contained  80-100  ml  of perfusate.  In  the 
absence of heparin, there was  no  loss of labeled 
protein from  the  lung perfusatc during a  60-min 
perfusion of the rat lung with [J25I]VLDL (Fig. 6). 
In contrast, the  inclusion of heparin  (2  U/ml) in 
the perfusing medium produced a significant, pro- 
gressive decline in levels of labeled protein in the 
perfusate. As shown in Fig. 7, the decline in total 
radioactivity of each  unfractionated  aliquot  was 
accompanied by a fall in delipidated TCA-insolu- 
ble radioactivity in the perfusate and by a  rise in 
TCA-soluble  radioactivity.  These  changes  oc- 
curred  most  rapidly during  the  initial 20  min  of 
perfusion. At this level of heparin (2 U/ml), there 
was net loss of [~25I]VLDL from the perfusate and 
a  progressive conversion  of labeled apolipopro- 
teins  to  catabolic end  products  measured  in  the 
aqueous  TCA-soluble  phases.  However,  when 
lower concentrations of heparin (0.1  U/ml) were 
present in the perfusate, there was no removal or 
catabolism of [~zsI]VLDL (Table II). Thus, some- 
what surprisingly, the  presence of heparin  (2  U/ 
ml) in the medium appeared to stimulate the up- 
take  and  degradation of the  protein  moieties of 
human  [125I]VLDL. 
In  contrast  to  the  results  with  human 
[~z'~I]VLDL, there was no uptake or degradation 
of labeled proteins when the lungs were perfused 
with  either  human  or  rat  [125I]LDL  or  with 
[~z'~I]albumin,  at  levels of heparin  that  had  been 
shown  to  promote  pulmonary  metabolism  of 
[~2:>I]VLDL (Fig.  8,  Table  II).  With  [~2">I]LDL, 
there were  no significant changes in radioactivity 
found in perfusate aliquots, in TCA-insoluble, or 
in TCA-soluble fractions over the course of perfu- 
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Experimental conditions as in preceding figures. LB, lamellar body; M, mitochondria, x  33,000. 
sion (Fig. 8).  Perfusion of the apparatus,  per se, 
with perfusing solution containing [~'~I]VLDL and 
heparin  (2  U/ml)  but  without  the  lung did  not 
produce any change in perfusate radioactivity (Ta- 
ble II). 
UPTAKE  AND  CATABOLISM  OF  RAT 
[I2'5I]VLDL:  In two experiments, rat lungs were 
perfused with medium containing rat  [12'~I]VLDL 
and  heparin  to  determine  whether  the  homolo- 
gous radioiodinated VLDL were metabolized in a 
fashion comparable to that of human [Iz~I]VLDL. 
The  results  of  the  two  experiments  were  very 
similar,  and  the  data  from  one  of  the  two  are 
depicted in Fig. 9. As shown in the figure, while 
the  total perfusate  radioactivity declined by only 
2% (Fig. 9 a) over 60 rain of perfusion, there were 
more  striking changes  in the  chemical  nature of 
the radioactive perfusate. Fractionation of the per- 
fusate  aliquots  revealed  a  15%  decline  in  the 
TCA-insoluble precipitates  of perfusate  over  60 
min of  perfusion.  Delipidation of these  precipi- 
tates demonstrated that this decline represented a 
FIGURE 2  Rat  lung perfused  with  [125I]VLDL and heparin. The  electron microscope  radioautogram 
illustrates the localization of silver grains over a capillary endothelial cell. The grains are in a region of the 
cytoplasm  containing numerous plasmalemmal vesicles  (PV)  and  few  profiles  of smooth  and  rough 
endoplasmic reticulum (arrows).  CAP,  capillary;  END,  endothelium; BL,  basal lamina; IC, interstitial 
cell.  x  100,000. 
FmURE 3  Another view of a capillary endothelial cell after perfusion of the lung with  [t25I]VLDL and 
heparin, (2 U/ml). Two silver grains are seen attached to the luminal surface of an endothelial cell. IS, 
interstitial space,  x  50,000. 
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showed no significant changes with time (Fig. 9 b). 
Moreover, the  TCA-soluble  radioactivity tripled 
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FmURE  5  Histogram comparing the  density of silver 
grains over the various compartments of the alveolar- 
capillary  barrier  in  rat  lungs  that  showed  uptake  of 
VLDL label. The results  are expressed as a mean grain 
density/100 /xm  z of compartment surface  -+  SEM. The 
label is  present in  all  tissue  compartments but with a 
significantly  higher density over the capillary  endothe- 
iium (P <  0.02). The background was 0.01/100/.tm  z. 
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Effect of heparin on metabolism of human 
[I~5I]VLDL by  the  isolated  perfused  rat  lung.  Eight 
isolated rat lungs were perfused with 1.5-7.0 mg human 
[12~I]VLDL in  absence (O-O;  3  animals)  or presence 
(x-  ￿  5 animals) of heparin (2.0 U/ml of perfusate). 
The labeled proteins were isolated by TCA-precipitation 
and were delipidated as described in  Methods. Proce- 
dures for perfusion of the lung and assay of the perfusate 
samples are  also described under Experimental Meth- 
ods. Various points represent mean changes in concen- 
tration of labeled protein (expressed as/xg of protein loss 
per 80 ml of perfusate which is the total starting volume 
of the perfusion medium); bars indicate  the SEM. The 
differences between mean values  at 20  min are signifi- 
cant at P  <  0.01. 
over  the  60  min,  and  this  rise  was  due  almost 
equally to rises in inorganic 125I label and in non- 
iodide  label  probably  representing  amino  acids 
and small peptides (Fig. 9 c). 
When  expressed  in  terms  of  labeled  protein 
TABLE  I 
Extraction of Radioactive Label from Lung  Tissue During Fixation and Dehydration 
Radioactivity 
Treatment  Sample  Perfusate*  Lung*  Aldehydesw  Buffer  washw  Acetonew 
[z25I]VLDL  and  1  50,800  1,160  244  89  9 
heparin  2  31,000  280  40  13  4 
3  31,000  300  14  6  8 
In each of two experiments, a rat lung was perfused for 60  min with heparin (2 U/ml) and human ['25I]VLDL in 
perfusion medium. At the end of the experiment, the lungs were washed free of intravascular  label by a postperfusion 
of 100 ml of unlabeled perfusion medium. Aiiquots of perfusate and fractions of homogenized lung as obtained in 
Methods were isolated and counted in a gamma counter. Samples no. 2 and 3 were obtained from two different areas 
of the same lung. 
* Cpm in 2-mi aliquots at 60 min. 
Cpm per 100 mg wet weight. 
w Cpm in 3 ml total volume. 
~ In this experiment, osmication and uranyl  acetate en bloc staining of lung tissue were omitted. 
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FIGURE  7  Decline  in total  perfusate radioactivity,  de- 
cline in TCA-insoluble, delipidated protein radioactivity, 
and rise in TCA-soluble material in five experiments in 
which isolated rat lungs were perfused with  1.5-6.0 mg 
human  [~2'~I]VLDL  and  heparin  (2  U/ml).  Results are 
expressed as mean percent change in perfusate radioac- 
tivity from baseline values; bars show SEM. The animals 
are the same as in Fig. 5 (x -  x). The other experimen- 
tal  details  are  outlined  under  Experimental  Methods. 
The differences between mean values at 0  and 60 min 
are significant at P  <  0.01. 
TABLE II 
Effect of Perfusing Isolated Rat Lungs with Heparin- 
ized Solution Containing ~V-Labeled Human Lipo- 
proteins or Albumin 
No. of  Labeled 
lungs  protein  Heparin  Uptake 
U/ml of  perfusate  #gig  lung/h 
2  VLDL  0.1  0 
5  VLDL  2  44.4 +-- 10.7w 
3  VLDL  -  0 
3  LDL  2  0 
3  Albumin$  2  0 
0*  VLDL  2  0 
" Lungs were omitted from perfusion system. 
$ nSI-labeled rat serum albumin. 
w SEM. 
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FIGURE  8  Lungs  were  isolated  from  three  rats  and 
perfused with 1.0-15.0 mg [~2SI]LDL and heparin (2 U/ 
ml) for 60 min as in Experimental Methods. Total perfu- 
sate, delipidated TCA-insoluble and TCA-soluble radio- 
activity are depicted. 
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FIGURE  9  In one experiment, lungs from one rat were 
peffused  with  medium  containing  595  /xg  of  rat 
[12sI]VLDL (1,680 cpm//.r  protein) and heparin (10 U/ 
ml). The  label  in  lipids in  the rat  VLDL  amounted to 
12%, with the remainder on the protein. The perfusate 
was fractionated at time 0, 30, and 60 min as described 
in Methods. (a)  Decline in concentration of radioactive 
label in 2-ml aliquots of perfusate during 60-min peffu- 
sion;  (b)  Decreasing radioactivity  in  the  perfusate is a 
result of loss of delipidated protein precipitate from the 
medium; (c)  The increase in TCA-soluble radioactivity 
corresponds to both an increase in iodide  and aqueous 
radioactivity. 
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139  p~g and 70  /~g of the starting labeled VLDL 
protein  were  removed  from  the  medium  by  60 
min. Of this total, 105/~g and 41/.,g, respectively, 
of labeled VLDL protein were converted to TCA- 
soluble material.  Surprisingly, in  neither experi- 
ment was there an observed decrease in the lipid 
extractable radioactivity in the medium (Fig. 9 b). 
Homogenates of lung postperfused with unlabeled 
medium in each of the two experiments revealed a 
retention of,  respectively, 1.5  /~g and  3.8  p.g of 
delipidated TCA-insoluble protein,  and  0.6  and 
1.7  p.g of noniodide TCA-soluble label. The dif- 
ference  in  iipoprotein  uptake  as  determined  by 
disappearance of radioactivity from the perfusate 
and by radioassay of the postperfused lung hom- 
genate  was  probably due  to  removal  of loosely 
bound  or trapped  iipoproteins by  the  unlabeled 
wash medium. Minimal amounts of ether-ethanol- 
soluble  radioactivity were  detected  in  the  lung 
homogenates  after  perfusion.  Of  the  total  lipid 
label initially present in the perfusate, only 0.5% 
and  1.6%,  respectively, were  found in the  lungs 
after 60 min. Thus, these two experiments provide 
convincing  evidence  for  the  uptake  of  rat 
[]'25I]VLDL protein and for conversion of a signifi- 
cant proportion of the labeled apolipoprotein ma- 
terial into catabolic products. 
PULMONARY  UPTAKE  AND  CATABOLISM 
OF  BIOLOGICALLY-LABELED  RAT  VLDL: 
In order to eliminate the possibility that iodination 
of lipoproteins in vitro altered these molecules and 
changed  their  biological  behavior,  experiments 
were  done  in  which  lungs  were  perfused  with 
VLDL labeled biologically either in vivo or in the 
isolated perfused rat liver (36). As shown in Fig. 
10,  all-labeled  rat  VLDL  obtained  by  in  vivo 
labeled amino acid injection was rapidly taken up 
by the  isolated rat  lung.  Since  only a  negligible 
amount  of this  batch  of VLDL  was  extractable 
with  either CHC13:CH3OH  or ether:ethanol, the 
disappearance of label from the perfusion medium 
clearly indicates an uptake of VLDL protein. As 
further shown in the figure, the decline in peffu- 
sate radioactivity occurred only when the lung was 
present in the system. In a second experiment with 
rat  VLDL,  protein-labeled by  perfusing  an  iso- 
lated  rat  liver with  ['4C]glycine (Fig.  11),  there 
was a rapid significant decline in delipidated TCA- 
insoluble protein in the lung perfusate, hence con- 
firming the  uptake  of the  protein portion of rat 
VLDL  by  the  rat  lung.  Thus,  both  biologically 
labeled  VLDL  which  circulated  in  vivo  in  the 
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FIGURE 10  [3H]Protein-labeled  rat  VLDL  was  pre- 
pared by injecting two rats, which had been fed a high 
(60%) carbohydrate diet for 5 days, with 1 mCi of a [all] 
labeled amino acid mixture. Plasma obtained by exsan- 
guination  3 h after the intravenous  injection was twice 
spun in the ultracentrifuge at d  =  1.006 as described in 
Methods. Only 1.5 % of the label was localized in VLDL 
lipids, with the remainder in the protein moiety.  Each 
point represents total radioactivity in a 2-ml aliquot of 
perfusate  of intervals up to 90 min of perfusion  of la- 
beled VLDL through  an isolated rat lung preparation. 
The lung was present  in the perfusion system between 
time 0 and 60 min. 
whole animal before its isolation, and biologically 
labeled  VLDL  released de  novo  from  the  liver 
were similarly removed by the rat lung during an 
in vitro perfusion. 
DISCUSSION 
Ample  evidence  now  exists  to  indicate  that  the 
lung plays an active role in lipid metabolism. Pre- 
vious reports have suggested that this organ catab- 
olizes the lipid moieties of chylomicra and that this 
lipid cargo may supply precursors for the synthesis 
of surfactant and cell membrane phospholipids (9, 
22,  23,  25).  The  lung  also  is  reported  to  be  a 
source of lipoprotein lipase activity that is partially 
releasable by heparin but is unaffected by fasting 
(22).  Felts has demonstrated that lung slices hy- 
drolyze VLDL  triglyceride and  incorporate TG- 
FA (15).  However, it is possible that VLDL hy- 
drolysis found in the latter study may be due  to 
release of tissue lipases, since, with organ  slices, 
leakage of protein and enzymes into the medium 
can  occur  (26,  28,  35).  However,  with  the  iso- 
lated, peffused rat lung, we could find no evidence 
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F]GUP.E  11  In this  experiment, the rat lung was  per- 
fused as previously described. However, the VLDL was 
biologically prepared  in vitro by a 3-h peffusion of an 
isolated  rat  liver  with KRB  containing  4%  BSA, 
[t4C]glydne,  [ff-I]glycerol, and  unlabeled  palrnitate 
(36). The perfusate was spun twice in the ultracentrifuge 
as described  in Methods,  and  the  supernatant-labeled 
VLDL was used for a rat  lung perfusion.  Aliquots of 
peffusate were precipitated with TCA and extracted with 
ether-ethanol  as in Methods.  Each point  represents  a 
mean  of duplicate  TCA-insoluble  protein  samples of 
perfusate obtained at various intervals. 
for  significant  removal  of  radioiodinated  lipid 
from  [~2~I]VLDL.  Similarly,  Hamosh  and  Ha- 
mosh (22, 23) found that uptake of the triglycer- 
ide  moiety of chylomicrons in  a  similar  in  vitro 
lung preparation was of very low magnitude. 
On the other hand,  our data strongly indicate 
that the isolated rat lung possesses  an unexpect- 
edly great capacity for catabolism of the protein 
moiety of VLDL. Pulmonary degradation  of la- 
beled VLDL apolipoproteins in the rat was dem- 
onstrated  with  both  rat  and  human  p2~I]VLDL 
and  with  two batches  of biologically labeled  rat 
VLDL. Radioautographic examination of the per- 
fused lung corroborated this finding. Interestingly, 
the proteolytic action of the  rat  lung on labeled 
VLDL appeared to be specific for this lipoprotein 
class  and  was  not  found  in  perfusions  with 
[1zsI]LDL or [12'~I]albumin. The physiological sig- 
nificance of our findings is unclear. However, the 
lung is known to be the source of other proteases 
with specific metabolic functions (16, 46, 50). 
Though a number of tissues are considered to 
have a capacity for the catabolism of lipoprotein 
peptides (4-6, 20, 47, 48), the present study pro- 
vides the first evidence that the lung may partici- 
pate in the proteolytic process. The prospect that 
this catabolic role of the lung may be physiologi- 
cally  important  is  suggested  by  the  anatomical 
position  of the  lungs  at  the  outlet  of the  liver 
where  VLDL  is  synthesized  and  released.  The 
pulmonary microcirculation is the initial  capillary 
bed traversed by newly formed VLDL, and there- 
fore  the  lung  may  perform  the  first  metabolic 
alterations of these molecules. In view of the ra- 
pidity of the  process and the predominant ultra- 
structural  localization  of developed  silver  grains 
over the alveolar endothelium, it is likely that this 
endothelium which possesses protease and dipep- 
tidase activities (46, 50) is largely responsible for 
the catabolic activity observed. 
Since only a negligible amount of radioactivity 
was removed by the lipid  solvents used to extract 
the  samples  of  postperfused  lung,  and  since 
[125I]VLDL iipids did not decline in the perfusion 
medium with time, the uptake of radioactive label 
by the lung probably represented  predominantly 
labeled peptides.  Clearly, a portion of the TCA- 
soluble  radioactivity  generated  in  experiments 
with rat [12'~I]VLDL  represented deiodination, but 
an equivalent amount was aqueous noniodide ra- 
dioactivity. The relatively large quantity of TCA- 
soluble,  noniodide  label that  accumulated in the 
perfusate  may indicate  proteolysis of VLDL oc- 
curring at the cell  surface and subsequent partial 
uptake of the catabolized products. Alternatively, 
it may result from release of small peptides and/or 
amino  acids  into  the  medium  after  intracellular 
hydrolysis of interiorized  VLDL. Thus, the lung 
appears to behave differently than  cultured arte- 
rial  smooth  muscle  cells  (4)  or  fibroblasts  (1) 
which take  up lipid  in disproportionately greater 
quantities than protein. 
The mechanism of the stimulatory effect of hep- 
arin on p25I]VLDL apoprotein catabolism by the 
lung is uncertain.  Since the effect on  [~2~I]VLDL 
catabolism  occurred  in  the  presence  of a  large 
excess (3 g/100 ml) of BSA, and was not observed 
with rat [~25I]LDL or [12'~IJalbumin, it is clear that 
there  is a high degree of specificity for this phe- 
nomenon.  Heparin  may bind  [~z'~I]VLDL to the 
endothelium  in  the  presence  of calcium  so  that 
peptidases  associated  with  the  surface  endothe- 
lium can digest the labeled protein. Alternatively, 
heparin  activation of a  pulmonary lipoprotein  li- 
pase  may  partially  hydrolyze  or  destabilize  the 
VLDL molecule, thereby rendering it readily sus- 
ceptible  to  proteolytic digestion.  The  possibility 
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endothelial protease which has a  substrate speci- 
ficity for VLDL apoproteins. Finally, it is possible 
that heparin releases proteases into the perfusate 
that digest [12sI]VLDL. The last possibility is most 
improbable because of the specificity of the prote- 
olysis for labeled VLDL even in the presence of a 
large excess of BSA. Nonetheless, the presence of 
heparin is essential to VLDL catabolism in the in 
vitro  preparation  we  used,  and  may  also  have 
physiological relevance since the pulmonary mast 
cells under in vivo conditions store large quantities 
of  this  sulfated  polysaccharide  (16).  Thus,  the 
present experiments strongly suggest that the lung 
provides  an  initial,  perhaps  critical  step  in  the 
remodelling of VLDL apoproteins which may in- 
fluence  the subsequent fate of these  lipoproteins 
as they travel to the heart and other extrahepatic 
tissues. 
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